Skip to main content
Log in

Expression of SKALP/elafin during wound healing in human skin

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Skin-derived antileukoproteinase (SKALP), also known as elafin, is a proteinase inhibitor with specificity for polymorphonuclear leucocyte (PMN)-derived elastase and proteinase-3. SKALP is absent in normal human epidermis, but is strongly induced in inflammatory dermatoses such as psoriasis. SKALP is putatively involved in the regulation of cutaneous inflammation by inhibiting PMN derived proteinases. The aim of this study was to investigate SKALP expression and PMN infiltration during wound healing in human skin. This was examined in healing excisional wounds in normal skin and in impaired healing in various types of chronic venous ulcers. Tissues were analysed using immunohistochemistry and Northern blot analysis. Healing of excisional wounds was studied from day 0 to day 14. An influx of PMN was seen rapidly after wounding and was maximal between day 2 and 4 and then subsided. SKALP was induced within 48 h and was expressed in the suprabasal keratinocytes of the wound edge and the migrating epidermal sheet. SKALP expression was maximal on day 4 and was downregulated at the time of complete reepithelialization (7–14 days). In venous ulcers, PMN were abundant in the wound bed and scarce under the wound edge. SKALP was strongly expressed in the keratinocytes of the wound edge in all types of ulcers studied. In the wound bed, SKALP was not detectable. Our results suggest that SKALP plays a role in the acute, inflammatory phase of wound healing. From the kinetics and topology of SKALP expression we surmise that it negatively regulates PMN infiltration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Alkemade H, Kerkhof P van de, Schalkqijk J (1992) Demonstration of skin-derived antileukoproteinase (SKALP) in urine of psoriatic patients. J Invest Dermatol 99:3–7

    Article  PubMed  CAS  Google Scholar 

  2. Alkemade HA, Molhuizen HO, Vlijmen Willems IM van, Haelst UJ van, Schalkwijk J (1993) Differential expression of SKALP/elafin in human epidermal tumors. Am J Pathol 143: 1679–1687

    PubMed  CAS  Google Scholar 

  3. Alkemade JAC, Molhuizen HOF, Ponec M, Kempenaar JA, Zeeuwen PLJM, Jongh GJ de, Vlijmen-Willems MJJ van, Erp PEJ van, Kerkhof PCM van de, Schalkwijk J (1994) SKALP/elafin is an inducible proteinase inhibitor in human epidermal keratinocytes. J Cell Sci 107:2335–2342

    PubMed  CAS  Google Scholar 

  4. Alkemade JAC, Jongh GJ de, Arnold WP, Kerkhof PCM van de, Schalkwijk J (1995) Levels of skin-derived antileukoproteinase (SKALP)/elafin in serum correlate with disease activity during treatment of severe psoriasis with cyclosporin A. J Invest Dermatol 104:189–193

    Article  PubMed  CAS  Google Scholar 

  5. Chang A, Schalkwijk J, Happle R, Kerkhof PC van de (1990) Elastase-inhibiting activity in scaling skin disorders. Acta Derm Venereol (Stockh) 70:147–151

    CAS  Google Scholar 

  6. Reference deleted

  7. Clark RAF (1993) Mechanisms of cutaneous wound repair. In: Westerhof W (ed) Leg ulcers: diagnosis and treatment. Elsevier Science, Amsterdam, pp 29–50

    Google Scholar 

  8. Clark RA, Winn HJ, Dvorak HF, Colvin RB (1983) Fibronectin beneath reepithelializing epidermis in vivo: sources and significance. J Invest Dermatol [Suppl] 80:26s-30s

    Article  PubMed  CAS  Google Scholar 

  9. Grinnell F, Zhu M (1994) Identification of neutrophil elastase as the proteinase in burn wound fluid responsible for degradation of fibronectin. J Invest Dermatol 103:155–161

    Article  PubMed  CAS  Google Scholar 

  10. Grinnell F, Ho CH, Wysocki A (1992) Degradation of fibronectin and vitronectin in chronic wound fluid: analysis by cell blotting, immunoblotting, and cell adhesion assays. J Invest Dermatol 98:410–416

    Article  PubMed  CAS  Google Scholar 

  11. Molhuizen HO, Alkemade HA, Zeeuwen PL, Jongh GJ de, Wieringa B, Schalkwijk J (1993) SKALP/elafin: an elastase inhibitor from cultured human keratinocytes. Purification, cDNA sequence, and evidence for transglutaminase cross-linking. J Biol Chem, 268:12028–12032

    PubMed  CAS  Google Scholar 

  12. Molhuizen HO, Zeeuwen PL, Olde Weghuis D, Geurts van Kessel A, Schalkwijk J (1994) Assignment of the human gene encoding the epidermal serine proteinase inhibitor SKALP (PI3) to chromosome region 20q12→q13. Cytogenet Cell Genet 66:129–131

    Article  PubMed  CAS  Google Scholar 

  13. Newman SL, Henson JE, Henson PM (1982) Phagocytosis of senescent neutrophils by human monocyte derived macrophages and rabbit inflammatory macrophages. J Exp Med 156: 430–442

    Article  PubMed  CAS  Google Scholar 

  14. Saheki T, Ito F, Hagiwara H, Saito Y, Kuroki J, Tachibana S, Hirose S (1992) Primary structure of the human elafin precursor preproelafin deduced from the nucleotide sequence of its gene and the presence of unique repetitive sequences in the prosegment. Biochem Biophys Res Commun 185:240–245

    Article  PubMed  CAS  Google Scholar 

  15. Sallenave JM, Ryle AP (1991) Purification and characterization of elastase-specific inhibitor. Sequence homology with mucus proteinase inhibitor. Biol Chem Hoppe Seyler 372:13–21

    PubMed  CAS  Google Scholar 

  16. Sallenave J, Schullmann J, Crosley J, Jordana M, Gauldie J (1995) Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Am J Resp Cell Mol biol 11:733–741

    Google Scholar 

  17. Reference deleted

  18. Schalkwijk J, Chang A, Janssen P, Jongh GJ de, Mier PD (1990) Skin-derived antileucoproteases (SKALPs): characterization of two new elastase inhibitors from psoriatic epidermis. Br J Dermatol 122:631–641

    Article  PubMed  CAS  Google Scholar 

  19. Schalkwijk J, Roo C de, Jongh GJ de (1991) Skin-derived antileukoproteinase (SKALP), an elastase inhibitor from human keratinocytes. Purification and biochemical properties. Biochim Biophys Acta 1096:148–154

    PubMed  CAS  Google Scholar 

  20. Schalkwijk J, Vlijmen IM van, Alkemade JA, Jongh GJ de (1993) Immunohistochemical localization of SKALP/elafin in psoriatic epidermis. J Invest Dermatol 100:390–393

    Article  PubMed  CAS  Google Scholar 

  21. Tonnesen MG, Worthen GS, Johnston RB (1988) Neutrophil emigration, activation, and tissue damage. In: Clark RAF, Henson PM (eds) Molecular and cellular biology of wound repair. Plenum Press, New York, pp 149–183

    Google Scholar 

  22. Weiss SJ (1989) Tissue destruction by neutrophils. N Engl J Med 320:365–376

    Article  PubMed  CAS  Google Scholar 

  23. Wiedow O, Schroder JM, Gregory H, Young JA, Christophers E (1990) Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence. J Biol Chem 265:14791–14795

    PubMed  CAS  Google Scholar 

  24. Wiedow O, Lüdemann J, Utecht B (1991) Elafin is a potent inhibitor of proteinase 3. Biochem Biophys Res Commun 174: 6–10

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Some of the results reported here were presented at the meeting of the European Society for Dermatological Research in Vienna, September 1994.

Rights and permissions

Reprints and permissions

About this article

Cite this article

van Bergen, B.H., Andriessen, M.P.M., Spruijt, K.I.J. et al. Expression of SKALP/elafin during wound healing in human skin. Arch Dermatol Res 288, 458–462 (1996). https://doi.org/10.1007/BF02505235

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02505235

Key words

Navigation